S
ANAB icon

Sanofi’s AnaptysBio ANAB Stock Holding History

Sanofi’s Portfolio ANAB Stock Details ANAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$55.5M Hold
821,917
– – 10.39% 4
2026
Q1 		$30.4M Hold
821,917
– – 9.04% 4
2025
Q4 		$39.8M Hold
821,917
– – 12.84% 4
2025
Q3 		$25.2M Hold
821,917
– – 9.67% 4
2025
Q2 		$18.2M Hold
821,917
– – 10.38% 3
2025
Q1 		$15.3M Hold
821,917
– – 9.21% 4
2024
Q4 		$10.9M Buy
+821,917
New +$19.9M 6.24% 4

Other funds holding ANAB

EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Sanofi's ANAB Position: Q2 2026 in Review

Sanofi held its AnaptysBio (ANAB) position steady in Q2 2026 at 821,917 shares worth $55.5M. The position accounts for 10.39% of the portfolio, ranked #4.

Sanofi first reported a position in ANAB in Q4 2024 and has held it in 7 quarters since. 213 funds tracked by Wall St. Rank hold ANAB as of Q2 2026.

  • Sanofi held 821,917 shares of AnaptysBio worth $55.5M as of Q2 2026.
  • Sanofi left its AnaptysBio share count unchanged in Q2 2026.
  • AnaptysBio made up 10.39% of Sanofi's portfolio in Q2 2026, its #4 holding.
  • Sanofi first reported a position in AnaptysBio in Q4 2024 and has held it in 7 quarters since.
  • 213 funds tracked by Wall St. Rank held AnaptysBio as of Q2 2026.

Based on Sanofi's 13F filing for Q2 2026, filed 28 Jul 2026.